Praxis Precision Medicines, Inc. PRAX Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s other income (expense)?
- Praxis Precision Medicines, Inc. (PRAX) reported other income (expense) of $13.3M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s other income (expense) changed year-over-year?
- Praxis Precision Medicines, Inc.'s other income (expense) increased by 144.8% year-over-year, from $5.43M to $13.3M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s other income (expense)?
- Over 4 years (2021 to 2025), Praxis Precision Medicines, Inc.'s other income (expense) has grown at a 203.3% compound annual growth rate (CAGR), from $271K to $22.93M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.